Here, Evelyne Priestman (Senior Consultant – HEOR) and Mary Baker (Senior Medical Writer) at Petauri Evidence explore the ...

AstraZeneca’s Imfinzi (durvalumab) has been granted priority review by the US Food and Drug Administration (FDA) to treat ...

Roche has shared new data from its Alzheimer’s disease (AD) development portfolio at this year’s Alzheimer’s Association ...

In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...

With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...

AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...

Novartis and Matchpoint Therapeutics have entered into a partnership worth $1bn to develop oral inhibitors for inflammatory ...

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

Pfizer and Astellas Pharma have shared positive top-line results from a late-stage study of their androgen receptor ...

AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...

Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track ...